«Caco-2 Cells

Below is an extended Caco-2 Cells patents listing. Click here to return to the Caco-2 Cells main in depth entry.

Patents :
US Patent No.	Title
7285556	Thienopyrimidine-based inhibitors of the src family
7319006	Serpentine transmembrane antigens expressed in human cancers and uses thereof
7321033	3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
7329733	Bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof
7332479	Extracellular NAD.sup.+ and cADPR as potent anti-inflammatory agents
7338939	Abuse-resistant hydrocodone compounds
7344880	Nucleic acid encoding PRO9912 polypeptides
7345150	Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
7348034	Plant based formulations for improving skin moisture, texture, and appearance
7348346	Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
7348420	Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
7316818	Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
7314959	Amino thiol compounds and compositions for use in conjunction with cancer therapy
7314632	Pseudomonas exotoxin A-like chimeric immunogens
7291334	Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7291598	Nanoparticles for protein drug delivery
7297511	Interferon alpha: remodeling and glycoconjugation of interferon alpha
7300794	Accelerated culture system for intestinal epithelial cell monolayers
7300956	Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
7303762	Absorption enhancers
7312192	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
7312208	Quaternary ammonium compounds
7312233	Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
7348475	Transgenic rice line producing high level of flavonoids in the endosperm
7351740	Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
7399474	Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
7399613	Sialic acid nucleotide sugars
7407787	Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
7413536	Substrates and screening methods for transport proteins
7413854	Method for synthesising templated molecules
7414154	Polyamine compounds and compositions for use in conjunction with cancer therapy
7415359	Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
7416858	Pharmaceutical compositions of glycoconjugates
7417023	Targeted delivery of bioaffecting compounds for the treatment of cancer
7417110	Biodegradable polyphosphoramidates for controlled release of bioactive substances
7396812	Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
7396680	Stem cell-specific promoters and their use
7393525	Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
7364905	Apparatus and method for high throughput analysis of compound-membrane interactions
7365157	PRO9912 polypeptides
7368547	Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of Listeria monocytogenes
7375082	Abuse-resistant hydrocodone compounds
7375083	Pharmaceutical compositions for prevention of overdose or abuse
7381702	Methods of treating diabetes mellitus
7381716	Nanoparticles for protein drug delivery
7384642	Canine influenza vaccines
7387791	Liposome drug delivery
7390519	Probiotic Lactobacillus salivarius strains
7417178	Expression of human milk proteins in transgenic plants

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.